News

An analysis of data from more than 9900 people with Down syndrome and 38,000 controls provides new insight into the apparent increase in risk of developing diabetes among children and young adults with Down syndrome.

Dr. Hyams, MD, discusses functional constipation in children and how positive results from a phase 3 trial on linaclotide will change treatment.

Hormonal implants are generally thought to be safe for bone, although whether a young adolescent would reach their genetically determined PBM while using a contraceptive implant is not known.

At the 2022 American Academy of Pediatrics National Conference & Exhibition, research was presented on which children are at high risk of severe COVID-19.

In a recent study, adolescents exposed to vaping prevention advertisements were less susceptible to vaping than those exposed to neutral videos discussing vaping.

Moderna has announced that their latest BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, has been granted Emergency Use Authorization by the US Food and Drug Administration.

Eagle Pharmaceuticals and Enalare Therapeutics have announced that their ENA-001 drug for the treatment of Apnea of Prematurity has been granted an Orphan Drug Designation by the US Food and Drug Administration.

In a recent study, trends of e-cigarette use among middle and high schoolers saw an increase in recent years.

In a recent study, pediatric patients with ADHD were less likely to be hospitalized from a mental disorder or need stimulant prescriptions when given general practitioner centered primary care.

At the American Academy of Pediatrics National Conference & Exhibition, Cassandra Padgett, MS, ACE health coach, discussed how telemedicine intervention effectively managed obesity in pediatric patients during the COVID-19 pandemic.

A recent study independently associated maternal obesity with ADHD risk in offspring, with a significant risk observed in joint obesity and excessive weight gain.

At the 2022 AAP National Conference & Exhibition, a professor of pediatrics describes the benefits of COVID-19 vaccines for children, safety considerations, and urges physicians to continue to urge caregivers to get their children vaccinated.

Natasha Sriraman, MD, general academic pediatrician, discusses the American Academy of Pediatrics conference that took place from October 7, 2022, to October 11, 2022.

In a session at the 2022 AAP National Conference & Exhibition, a physician presenter enumerates unique challenges in treating emerging infectious diseases in children and takes a look at the current pediatric COVID-19 therapies—and evidence gaps.

Sema4|GeneDx has announced its partnership in the GUARDIAN study, a collaboration for screening newborns through whole genome sequencing.

At the 2022 AAP National Conference & Exhibition, one session reviews pediatric considerations for dosing, safety, and regulatory approval for medications and vaccines for SARS-CoV-2, and a look at the Pediatric Trials Network.

Devyani Chowdhury, MD, discusses her session on syncope in young children at the 2022 AAP National Conference & Exhibition.

The approval, awarded to Alnylam Pharmaceuticals, is based on the results of the ILLUMINATE-C phase 3 trial.

Although crude results of a study showed risk of neurodevelopmental disorders doubling when exposed to antidepressants during pregnancy, these results were not observed in a fully adjusted analysis.

An analysis of trends has shown overall substance use among adolescents to decrease, while cannabis use and vaping have risen.

The American Academy of Pediatrics has released a join policy statement with the American College of Emergency Physicians and the Emergency Nurses Organizations discussing how child safety can be optimized in emergency settings.

Study links discrepancy to adults’ misbeliefs about vaccine safety.

In a recent study, access to pediatric palliative care was found to be lacking, despite the benefits it provides.

A recent study found that parent management training programs which incorporated time-out as a behavioral response are just as effective in children with history of adverse child experiences (ACE) as those without ACE history.

In a recent study, severe COVID-19 made up 8% of cases among neonates aged less than 28 days.

In a recent presentation at at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference, Carri Holton, MSN, WHNP, discussed gynecological complications that adolescents may face and offered practical treatment options.

In a recent study, investigators found that children from socioeconomically depraved families were more likely to be hospitalized from COVID-19.

Mimi Winsberg, MD, chief medical officer at Brightside Health, discusses new data on how telehealth intervention is efficient at reducing suicidal ideation when implemented correctly.